Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 6145 | 245 | 0.3089 | 0.3648 | 0.0399 | 0.0413 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 3 | 17737 | 603 | 1.0777 | 1.0016 | 0.0340 | 0.0383 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 11677 | 368 | 0.7113 | 0.6866 | 0.0315 | 0.0312 |
WM-115 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 3709 | 210 | 0.8363 | 0.8635 | 0.0566 | 0.0685 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 10880 | 316 | 0.6645 | 0.6866 | 0.0290 | 0.0312 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16963 | 834 | 0.7730 | 0.8197 | 0.0492 | 0.0506 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 11246 | 370 | 0.6841 | 0.6866 | 0.0329 | 0.0312 |
COLO 858 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 3 | 6029 | 760 | 0.9502 | 1.0000 | 0.1261 | 0.1418 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 5745 | 285 | 0.3434 | 0.2974 | 0.0496 | 0.0491 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 18341 | 936 | 0.8341 | 0.8197 | 0.0510 | 0.0506 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 5681 | 246 | 0.3419 | 0.2974 | 0.0433 | 0.0491 |
WM-115 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 1877 | 148 | 0.4133 | 0.4405 | 0.0788 | 0.0768 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 3476 | 189 | 0.2068 | 0.2974 | 0.0544 | 0.0491 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20940 | 1098 | 1.0048 | 1.0000 | 0.0524 | 0.0504 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 18747 | 969 | 0.8520 | 0.8197 | 0.0517 | 0.0506 |
COLO 858 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 2 | 6456 | 909 | 1.0004 | 1.0000 | 0.1408 | 0.1418 |
A-375 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 9567 | 390 | 0.4398 | 0.4342 | 0.0408 | 0.0408 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 4700 | 704 | 0.4744 | 0.5301 | 0.1498 | 0.1528 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 2 | 3870 | 269 | 0.9108 | 0.9197 | 0.0695 | 0.0725 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 3 | 3981 | 292 | 0.9331 | 0.9197 | 0.0733 | 0.0725 |
A-375 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 10229 | 430 | 0.4696 | 0.4342 | 0.0420 | 0.0408 |
COLO 858 | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 1 | 5564 | 919 | 0.8377 | 0.9265 | 0.1652 | 0.1634 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 5949 | 318 | 0.2851 | 0.2714 | 0.0535 | 0.0654 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 3244 | 144 | 0.9829 | 0.9268 | 0.0444 | 0.0478 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 4472 | 217 | 1.3491 | 0.9268 | 0.0485 | 0.0478 |